Dépakine: a barcode defect on a small number of boxes raises fears of a risk of overdose for the patient. Sanofi assured that a “large part of the boxes” affected by this defect had however “been taken out of the circuit” The pills of the two dosages do not have “the same shape”, emphasizes Sanofi.
The antiepileptic drug was at the center of a health scandal in 2015 following malformations in children.